Mesti, T. (2018) “NMR Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells”, Radiology and Oncology, 52(4). Available at: https://radioloncol.com/index.php/ro/article/view/2963 (Accessed: 21 July 2026).